Health Reimagined

Predictive & Personalized Health

We enable personalized, pro-active health management through breath

❋ Breath Biomarkers

When our health is deprived, the balance of molecules (biomarkers) in breath changes, often even before you feel symptoms.

❋ Disease screening & early diagnosis

Specific biomarkers can be used as early warning or diagnosis system for specific diseases such as COPD or lung cancer.

❋ Personalized & predictive

Our system knows how to interpret your unique breath biomarker profile, resulting in a unique personalized health status.

We detect breath biomarkers at extremely low concentrations, making our solution highly sensitive and clinically relevant.

❋ Sensitive & accurate

Breath analysis made easy: a single breath lets you regain control over your health

Our approach explained

  • We deliver health insights to health professionals and, eventually, consumers. Our first device will be available to health professionals to help people better understand their repiratory and gut health. Ultimately our device will be available to patients and consumers.

  • Analyzing your breath is simple: simply exhale into our mouthpiece and our device will do the rest. Results will be available real-time.

  • We combine a high biomarker sensitivity and specificity with ease of use and compactness, bringing lab-grade analytical capabilities to the point of care.

  • We measure volatile organic compounds that are uniquely correlated with the conditions of interest. Our technology captures the full spectrum of compounds every time you exhale, and our system can analyze the relevant compounds on demand.

  • We offer our device as a service (hardware-as-a-service). This way we can provide you with the ability to collect data and expand into new health domains by software updates.

  • We are currently open to connect to clinics and healthcare professionals focusing on COPD, Food Intolerance, SIBO and IBS. If you are a patient, please refer your healthcare provider to us.

Pipeline

Focus Areas

We focus on supporting early diagnosis and chronic disease management at first. Within this group, we focus on Gut and Respiratory health.

Disease area
Start date
Status

COPD

2024

Clinical trials


Food Intolerance

2024

Clinical trials


SIBO

2026

R&D


Asthma

2026

R&D


Lung cancer

2027

R&D


Our Partners

Partner with us